(Q34984079)

5 August 2017

1 reference

title

Optimal therapy of hepatitis C. (English)

1 reference

5 August 2017

Adrian M. Di Bisceglie

series ordinal

1

object named as

Adrian M Di Bisceglie

1 reference

5 August 2017

Jay H Hoofnagle

2

1 reference

PubMed ID

12407585

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

36

1 reference

5 August 2017

S121-7

1 reference

5 August 2017

5 Suppl 1

1 reference

Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group

5 August 2017

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36228

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36228

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36228

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36228

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36228

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36228

National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36228

Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36228

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.36228

1 reference

5 August 2017

1 reference

PubMed ID

12407585